<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: beta-Adrenoreceptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> provide neuroprotection against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, but the effects of these <z:chebi fb="68" ids="48706">antagonists</z:chebi> on experimental global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>That is, the effect of beta-adrenoreceptor antagonism in vulnerable brain regions after ischemic insult has not been examined </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we investigated the neuroprotective effects of preischemic or postischemic administration of <z:chebi fb="2" ids="8499">propranolol</z:chebi> (a nonselective beta-adrenoreceptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>), esmolol, and landiolol (selective beta-adrenoreceptor 1 antagonists) against forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: IV administration of saline 10 microL  </plain></SENT>
<SENT sid="4" pm="."><plain>h(-1), <z:chebi fb="2" ids="8499">propranolol</z:chebi> 100 microg  </plain></SENT>
<SENT sid="5" pm="."><plain>kg(-1)  </plain></SENT>
<SENT sid="6" pm="."><plain>min(-1), esmolol 200 microg  </plain></SENT>
<SENT sid="7" pm="."><plain>kg(-1)  </plain></SENT>
<SENT sid="8" pm="."><plain>min(-1), or landiolol 50 microg  </plain></SENT>
<SENT sid="9" pm="."><plain>kg(-1)  </plain></SENT>
<SENT sid="10" pm="."><plain>min(-1) in male Sprague-Dawley rats was started 30 minutes before or 60 minutes after 8-minute bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with <z:hpo ids='HP_0002615'>hypotension</z:hpo> (35 mm Hg) under <z:chebi fb="0" ids="6015">isoflurane</z:chebi> (1.5%) anesthesia </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> drugs were administered continuously until 5 days after reperfusion, and the animals were evaluated neurologically and histologically after this 5-day period </plain></SENT>
<SENT sid="12" pm="."><plain>RESULTS: Preischemic treatment with <z:chebi fb="2" ids="8499">propranolol</z:chebi>, esmolol, or landiolol failed to provide neuroprotection against forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the hippocampus </plain></SENT>
<SENT sid="13" pm="."><plain>Rats treated with <z:chebi fb="2" ids="8499">propranolol</z:chebi> tended to have a worse score for motor activity and a higher mortality rate (up to 64%), but the differences with other groups were not statistically significant </plain></SENT>
<SENT sid="14" pm="."><plain>Postischemic treatment with esmolol and landiolol, but not with <z:chebi fb="2" ids="8499">propranolol</z:chebi>, reduced neuronal injury after forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>However, motor activity did not differ among rats treated postischemically with any of the beta-adrenoreceptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> or saline </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: Postischemic treatment with esmolol and landiolol provided neuroprotection in the hippocampus in rats subjected to bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with hemorrhagic shock, whereas treatment with <z:chebi fb="2" ids="8499">propranolol</z:chebi> failed to show neuroprotection </plain></SENT>
<SENT sid="17" pm="."><plain>We suggest that concomitant beta-blockade and shock might work as a systemic depressant, rather than a neuroprotectant, resulting in exacerbation of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>